Register of
Medicinal Products

Product class: Authorized package
Medicinal product class: Veterinary medicine
Package code: 1705946
Name of medicinal product: Apravet
Active substances:
Apramycin
Estonian, English, Latin
ATC code: QA07AA92
Dosage form: powder for use in drinking water/milk
Route of administration: in drinking water/milk use
Strengh: 552RÜ 1mg
Amount in package: 50000000RÜ 1TK
Legal status for supply*: Subject to medicinal prescription
Class of active substance:  
Additional information:  
Indication: Pigs (weaned piglets): Treatment of bacterial enteritis caused by Escherichia coli susceptible to apramycin. Pre-ruminant calves: Treatment of bacterial enteritis caused by Escherichia coli and clinical outbreaks due to Salmonella enterica subsp. enterica serovar Dublin (Salmonella Dublin) susceptible to apramycin. Treatment should be based on prior confirmation of the Salmonella serovars involved or at least the availability of epidemiological data confirming the presence of this serovar. Chickens: Treatment of colibacillosis caused by Escherichia coli susceptible to apramycin. Rabbits: Treatment and metaphylaxis of bacterial enteritis caused by Escherichia coli susceptible to apramycin. The presence of the disease in the herd must be established before the product is used.
Safety features: No
Summary of product characteristics (SPC):  (last updated October 9, 2018)
Package information leaflet (PIL): EST  (last updated October 9, 2018)
Labelling:  (last updated October 9, 2018)
Withdrawal time: Siga: Lihale ja söödavatele kudedele: 0 päeva. Vasikas: Lihale ja söödavatele kudedele: 28 päeva. Kana: Lihale ja söödavatele kudedele: 0 päeva. Mitte kasutada lindudel, kelle mune tarvitatakse või kavatsetakse tarvitada inimtoiduks. Mitte kasutada 4 nädala jooksul enne munemisperioodi algust. Küülik: Lihale ja söödavatele kudedele: 0 päeva.
Species: küülik, siga, veis (vasikas), kana
Last imported to Estonia: Never imported to Estonia
Marketing authorization holder: Huvepharma 
Marketing authorization number: 2114 
Marketing authorization issued on: October 9, 2018 
Marketing authorization expires on: October 9, 2023 
Marketing authorization procedure type: Decentralised 
Entry/Changing date: May 19, 2022
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere